Home > Compound List > Product Information
Hydrocortisone hemisuccinate_Molecular_structure_CAS_83784-20-7)
Click picture or here to close

Hydrocortisone hemisuccinate

Catalog No. Bio-0653 Name InterBioScreen
CAS Number 83784-20-7 Website http://www.ibscreen.com
M. F. C25H34O8 Telephone +7 49652 40091
M. W. 462.53266 Fax
Purity Email screen@ibscreen.chg.ru
Storage Chembase ID: 109323

SYNONYMS

IUPAC name
4-{2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadec-6-en-14-yl]-2-oxoethoxy}-4-oxobutanoic acid
IUPAC Traditional name
4-{2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadec-6-en-14-yl]-2-oxoethoxy}-4-oxobutanoic acid

DATABASE IDS

CAS Number 83784-20-7

PROPERTIES

Application(s) Antiinflammatory
Application(s) Antiallergic agent
Application(s) Immunosuppressive
Mechanism of Action Glucocorticoid
Mechanism of Action ACTH antagonist
Mechanism of Action ACTH secretion inhibitor
Mechanism of Action Immunosuppressive
Mechanism of Action Phosphorus-mobilizer
Mechanism of Action Gluconeogenesis promoter
Mechanism of Action Glycogen deposition inhibitor
Mechanism of Action Calcium mobilizer

DETAILS

REFERENCES

  • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 584C, (nmr)
  • Reichstein, T., Helv. Chim. Acta, 1937, 20, 953, (isol)
  • v. Euw, J. et al., Helv. Chim. Acta, 1942, 25, 988, (struct)
  • Zaffaroni, A. et al., J.A.C.S., 1951, 73, 1390, (biosynth)
  • Wendler, N.L. et al., J.A.C.S., 1951, 73, 3818, (synth)
  • Heller, E., Z. Naturforsch., B, 1959, 14, 298, (ir)
  • U.S. Pat., 1960, 2 936 313; CA, 54, 19783, (phosphate)
  • Shirasaka, M., Chem. Pharm. Bull., 1961, 9, 152, (synth)
  • Saucy, G. et al., Helv. Chim. Acta, 1966, 49, 1529; 1967, 50, 1394, (synth, ir, uv, pmr)
  • van der Sijde, D. et al., Rec. Trav. Chim. (J. R. Neth. Chem. Soc.), 1966, 85, 721, (synth)
  • Smit, A. et al., Rec. Trav. Chim. (J. R. Neth. Chem. Soc.), 1966, 85, 731, (synth, struct, pmr)
  • Bhacca, N.S. et al., J.A.C.S., 1973, 95, 8421, (cmr)
  • Haskins, N.J. et al., Biomed. Mass Spectrom., 1974, 1, 423, (ms)
  • Fiegel, G., Arzneim.-Forsch., 1975, 25, 560, (use)
  • Ger. Pat., 1979, 2 826 257; CA, 93, 26657, (butyrate, propionate)
  • Genard, P., Org. Mass Spectrom., 1979, 12, 396, (pmr)
  • Castellano, E.E. et al., Acta Cryst. B, 1980, 36, 3063, (cryst. struct)
  • Florey, K., Anal. Profiles Drug Subst., 1983, 12, 277, (rev, synth, pharmacol, anal)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 6346; 6986; 7335
  • Minagawa, K. et al., J.C.S. Perkin 1, 1988, 587, (synth)
  • Kirk, D.N. et al., J.C.S. Perkin 2, 1990, 1567, (pmr)
  • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 734
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, BAV275; HHR000; CNS750; HHQ800; HHQ825; HHQ850; HHQ875